The semi-annual meeting of the Regulatory Education and Action for Patients consortium was held in Washington, DC on January 17, 2013. The topics discussed focused on the current political landscape post-election and looking forward over the next two years along with the future of healthcare reform, improper payments in federal safety net programs (Medicare/Medicaid), an update on the patient focused drug development program in progress at the FDA and an update from the REAP workgroups.
Click here to read a recap of the January meeting highlights.
The REAP consortium currently has 53 member organizations across a wide variety of patient advocate groups, all coming together for a common cause - to promote the voice of patients to policy makers and regulators. This consortium began in 2010 with a few organizations and authored one collaborative comment letter to lawmakers, was signed by 6 organizations. By the end of 2012, the consortium had submitted 10 comment letters total, and the last comment letter was signed by 32 groups, including the CLF, who was also a member of the workgroup that developed the response. The comment letter outlined several detailed recommendations for clarity and transparency surrounding the proposed rule published by the Department of Health and Human Services (HHS) that helps consumers shop for and compare non-grandfathered private health insurance options in the individual and small group markets by promoting consistency across plans and protecting consumers by ensuring that plans cover a core package of items and services. Otherwise referred to as Essential Health Benefits.